Shedding natural light on fungal infections

Virulence

Volumn 3, Issue 1, 2012, Pages 15-17

  Vecchiarelli, Anna ^a   d'Enfert, Christophed ^b  

^a Microbiology Section   (Italy)

^b INSTITUT PASTEUR   (France)

Author keywords

Aspergillus; Bioluminescence imaging; Candida; Fungal infection; Fungi; Luciferase; Opportunistic infection

Indexed keywords

ANALYTIC METHOD; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BIOLOGICAL MONITORING; BIOLUMINESCENCE; CANDIDA ALBICANS; DERMATOMYCOSIS; DIAGNOSTIC VALUE; DISEASE COURSE; EUKARYOTE; MYCOSIS; NONHUMAN; PATHOGENESIS; SENSITIVITY ANALYSIS;

ANIMALIA; ASPERGILLUS; ASPERGILLUS FUMIGATUS; BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; EUKARYOTA; FUNGI; GAUSSIA PRINCEPS (T. SCOTT, 1894);

EID: 84858244722     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.3.1.19247     Document Type: Article

References (19)

1. Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 2011. In press. PMID:22158429; http://dx.doi.org/10.1038/nrmicro2711
2. McCormick A, Loeffler J, Ebel F. Aspergillus fumigatus: contours of an opportunistic human pathogen. Cell Microbiol 2010; 12:1535-1543; PMID:20716206; http://dx.doi.org/10.1111/j.1462-5822.2010.01517.x
3. Hutchens M, Luker GD. Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol 2007; 9:2315-2322; PMID:17587328; http://dx.doi.org/10.1111/j.1462-5822.2007.00995.x
4. Enjalbert B, Rachini A, Vediyappan G, Pietrella D, Spaccapelo R, Vecchiarelli A, et al. A multifunctional,synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections. Infect Immun2009; 77:4847-4858; PMID:19687206; http://dx.doi.org/10.1128/IAI.00223-09
5. Pietrella D, Rachini A, Torosantucci A, Chiani P, Brown AJ, Bistoni F, et al. A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine 2010; 28:1717-1725; PMID:20038431; http://dx.doi.org/10.1016/j.vaccine.2009.12.021
6. Robertson LA, Figge MJ, Dunlap PV. Beijerinck and the bioluminescent bacteria: microbiological experiments in the late 19th and early 20th centuries. FEMS Microbiol Ecol 2011; 75:185-194; PMID:21133957; http://dx.doi.org/10.1111/j.1574-6941.2010.01004.x
7. Srikantha T, Chandrasekhar A, Soll DR. Functional analysis of the promoter of the phase-specific WH11 gene of Candida albicans. Mol Cell Biol 1995; 15: 1797-1805; PMID:7862169
8. Doyle TC, Nawotka KA, Purchio AF, Akin AR, Francis KP, Contag PR. Expression of firefly luciferase in Candida albicans and its use in the selection of stable transformants. Microb Pathog 2006; 40:69-81; PMID: 16427765; http://dx.doi.org/10.1016/j.micpath.2005.11.002
9. Doyle TC, Nawotka KA, Kawahara CB, Francis KP, Contag PR. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene. Microb Pathog 2006; 40:82-90; PMID:16426810; http://dx.doi.org/10.1016/j.micpath.2005.11.003
10. Brock M. Application of bioluminescence imaging for in vivo monitoring of fungal infections. Int J Microbiol 2012; 2012:956794; PMID:22121368; http://dx.doi.org/10.1155/2012/956794
11. Pietrella D, Rachini A, Pines M, Pandey N, Mosci P, Bistoni F, et al. Th17 cells and IL-17 in protective immunity to vaginal candidiasis. PLoS One 2011; 6: e22770; PMID:21818387; http://dx.doi.org/10.1371/journal.pone.0022770
12. Fidel PL, Jr., Cutler JE. Prospects for development of a vaccine to prevent and control vaginal candidiasis. Curr Infect Dis Rep 2011; 13:102-107; PMID:21308461; http://dx.doi.org/10.1007/s11908-010-0143-y
13. Pietrella D, Angiolella L, Vavala E, Rachini A, Mondello F, Ragno R, et al. Beneficial effect of Mentha suaveolens essential oil in the treatment of vaginal candidiasis assessed by real-time monitoring of infection. BMC Complement Altern Med 2011; 11:18; PMID:21356078; http://dx.doi.org/10.1186/1472-6882-11-18
14. Dai T, Bil de Arce VJ, Tegos GP, Hamblin MR. Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Antimicrob Agents Chemother 2011; 55:5710-5717; PMID:21930868; http://dx.doi.org/10.1128/AAC.05404-11
15. Brock M, Jouvion G, Droin-Bergère S, Dussurget O, Nicola MA, Ibrahim-Granet O. Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Appl Environ Microbiol 2008; 74:7023-735; PMID: 18820063; http://dx.doi.org/10.1128/AEM.01288-08
16. Ibrahim-Granet O, Jouvion G, Hohl TM, Droin-Bergère S, Philippart F, Kim OY, et al. In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis. BMC Microbiol 2010; 10:105; PMID:20377900; http://dx.doi.org/10.1186/1471-2180-10-105
17. Donat S, Hasenberg M, Schäfer T, Ohlsen K, Gunzer M, Einsele H, et al. Surface display of Gaussia princeps luciferase allows sensitive fungal pathogen detection during cutaneous aspergillosis. Virulence 2012; In press.
18. Ben-Ami R, Lewis RE, Leventakos K, Latgé JP, Kontoyiannis DP. Cutaneous model of invasive aspergillosis. Antimicrob Agents Chemother 2010; 54:1848-1854; PMID:20145078; http://dx.doi.org/10.1128/AAC.01504-09
19. d'Enfert C, Vecchiarelli A, Brown AJ. Bioluminescent fungi for real-time monitoring of fungal infections. Virulence 2010; 1:174-176; PMID:21178436; http://dx.doi.org/10.4161/viru.1.3.11119